Understanding neurodegenerative diseases and developing potential treatments requires researchers worldwide to collaborate and share their learnings. This demands consistent and standardized data to compare the research findings. The absence of such a data-sharing system hinders understanding these diseases and potential treatments.
A global biotech company partnered with a non-profit medical research organization and Nagarro to build a solution to make Alzheimer's disease data easily accessible and comparable.
We designed and developed a web-based platform to bring together researchers, biostatisticians, data scientists, and other experts involved in improving the understanding of Alzheimer's biomarkers. The solution enables hundreds of researchers to collaborate and share their findings for better treatment of Alzheimer's.